MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics...
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
Vitiligo Repigmentation Achieved in Five Treatments with XTRAC® Excimer Laser HORSHAM, Pa., March 15, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: SSKN)...
PRESS RELEASE March 15, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that...
SAN CARLOS, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions...
Jeff Bornstein, M.D. to serve as Chief Medical Officer and Paul Little as Chief Financial OfficerIRVINE, Calif., March 15, 2021...
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...
The Journal of Medical Economics shows that implementing Wellframe reduced inpatient admissions by 17%BOSTON, March 15, 2021 (GLOBE NEWSWIRE) --...
MARKHAM, Ontario, March 15, 2021 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has...
SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development...
-- BMB compound significantly reduced fentanyl intake in an animal model of opioid abuse -- -- Potential to reduce continued...
Oryzon will consequently proceed to file an IND applicationPORTICO will be developed in several US and European sites MADRID, Spain...
2020 Revenues Increase Over 330% Year-over-Year to Record $3.2 Million Murata Confirms XBAR® Performance and Moves Into Manufacturing Development Phase...
Announced signing of transaction transferring Ovid’s 50% of global rights to develop and commercialize soticlestat (TAK-935/OV935) to Takeda, under which...
Novel UCSF investigator led Phase 2 clinical study to address role of epigenetic therapy in mitigating resistance to immune-oncology drugsCALGARY,...
MONTREAL, March 15, 2021 (GLOBE NEWSWIRE) -- Semeon Analytics, an ATW Tech Inc. company, and Adexflow international are joining forces...
SAINT LAURENT, Quebec, and NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the “Corporation”) today...
Filter Drugs By Development Phase and Type RECCE® 327 (R327) has been added to The Pew Charitable Trusts’ annual list...
Data provides first-in-patient mechanistic proof-of-concept for ATYR1923. ATYR1923 reduced key inflammatory cytokines that are implicated in sarcoidosis and other ILDs,...
Completion of balstilimab BLA filing on target for 1H 2021New clinical data for AGEN1181 to be presented at AACRTIGIT bispecific...